PeptidePicker
Home/Peptides/Livagen
BioregulatorResearch

Livagen

Also known as: Lys-Glu-Asp-Ala · KEDA

A tetrapeptide bioregulator for hepatic regeneration and epigenetic reprogramming, proven to decondense heterochromatin in elderly individuals.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~30 minutes

Typical Dose

10 mg daily (oral, cycled)

Administration

Oral capsule

Mechanism of Action

Activates liver-specific gene expression and physically opens condensed chromatin in aging hepatocytes, restoring transcriptional activity.

Key Research Areas

bioregulatorliverepigeneticchromatin

Frequently Asked Questions

What is Livagen?
A tetrapeptide bioregulator for hepatic regeneration and epigenetic reprogramming, proven to decondense heterochromatin in elderly individuals.
How does Livagen work?
Activates liver-specific gene expression and physically opens condensed chromatin in aging hepatocytes, restoring transcriptional activity.
What is the recommended dosage for Livagen?
The typical research dosage is 10 mg daily (oral, cycled), administered via Oral capsule. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Livagen?
The half-life of Livagen is approximately ~30 minutes. This affects dosing frequency and timing in research protocols.
Is Livagen FDA approved?
Livagen is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.

Research Disclaimer

The information provided about Livagen is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Bioregulator